Figure 2.
Distribution of ICH size in patients with and without antiplatelet agent exposure. Number of ICHs in the cohort receiving antiplatelet agents (upper panel) and controls (lower panel), according to volume (cm3). The volume distribution was similar in the 2 groups (P = .49, Wilcoxon rank-sum test).